TCR-mediated up-regulation of c-FLIP(short) correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity

Journal of Immunology

Volumn 165, Issue 11, 2000, Pages 6293-6300

  Kirchhoff, S ^a   Muller, W W ^a   Krueger, A ^a   Schmitz, I ^a   Krammer, P H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CD3 ANTIGEN; FAS ANTIGEN; INHIBITOR PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 2; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0034548714     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.11.6293     Document Type: Article

References (49)

1. Monoclonal antibody-mediated tumor regression by induction of apoptosis
2. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
3. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor
4. FADD/MORTI is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis
5. The receptor for the cytotoxic ligand TRAIL
6. TRAIL-R2: A novel apoptois-mediating receptor for TRAIL
7. Death-receptors: Signaling and modulation
8. Fas ligand mediates activation-induced cell death in human T lymphocytes
9. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
10. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
11. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
12. A novel protein that interacts with the death domain of Fas/APO-1 contains a sequence motif related to the death domain
13. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
14. Involvement of MACH, a novel MORTI/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
15. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex
16. The Ced-3/interleukin-1β converting enzyme-like homologue Mch6 and lamin-cleaving enzyme Mch2α are substrates for the apoptotic mediator CPP32
17. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
18. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
19. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
20. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
21. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
22. Inhibition of Fas death signals by FLIPs
23. Viral Flice-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
24. 1-FL1CE, a novel inhibitor of tumor necrosis factor receptor-1- and CD95-induced apoptosis
25. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis
26. Inhibition of death receptor signals by cellular FLIP
27. CASH, a novel caspase homologue with death effector domains
28. Casper is a FADD- and caspase-related inducer of apoptosis
29. Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L)
30. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis
31. MRIT, a novel death-effector domain-containing protein, interacts with caspases and Bcl-X(L) and initiates cell death
32. Cell death attenuation by 'Usurpin,' a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD95 (Fas, APO-1) receptor complex
33. The role of c-FLIP in modulation of CD95-induced apoptosis
34. Direct physical interaction between the Caenorhabditis elegans 'death proteins' CED-3 and CED-4
35. Activation interferes with the APO-1 pathway in mature human T cells
36. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells
37. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death
38. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis
39. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens
40. FLICE is predominantly expressed as two functionally active isoforms, caspsase-8/a and caspase-8/b
41. Resistance of cultured peripheral T cells toward activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex
42. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells
43. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
44. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells
45. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
46. Reactive oxygen species regulate activation-induced T cell apoptosis
47. Selective up-regulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: A mechanism fr Th2 resistance from Fas-mediated apoptosis
48. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
49. Autoimmunity as a consequence of retrovirus-mediated expression of c- FLIP in lymphocytes